5-Fluoro-2-methylbenzoic acid structure
|
Common Name | 5-Fluoro-2-methylbenzoic acid | ||
---|---|---|---|---|
CAS Number | 33184-16-6 | Molecular Weight | 154.138 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 262.1±20.0 °C at 760 mmHg | |
Molecular Formula | C8H7FO2 | Melting Point | 130-132 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 112.3±21.8 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | 5-Fluoro-2-methylbenzoic acid |
---|---|
Synonym | More Synonyms |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 262.1±20.0 °C at 760 mmHg |
Melting Point | 130-132 °C(lit.) |
Molecular Formula | C8H7FO2 |
Molecular Weight | 154.138 |
Flash Point | 112.3±21.8 °C |
Exact Mass | 154.043015 |
PSA | 37.30000 |
LogP | 2.62 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.533 |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S37/39 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2916399090 |
~60% 5-Fluoro-2-meth... CAS#:33184-16-6 |
Literature: ALANTOS PHARMACEUTICALS, INC. Patent: WO2006/116157 A2, 2006 ; Location in patent: Page/Page column 83 ; WO 2006/116157 A2 |
Precursor 1 | |
---|---|
DownStream 10 | |
HS Code | 2916399090 |
---|---|
Summary | 2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
Multkilogram Scale-Up of a Reductive Alkylation Route to a Novel PARP Inhibitor. Gillmore AT, et al.
Org. Process Res. Dev. 16(12) , 2063-72, (1999)
|
|
Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.
Bioorg. Med. Chem. 19 , 4935, (2011) HIV-1 integrase (IN) is a validated therapeutic target for antiviral drug design. However, the emergence of viral strains resistant to clinically studied IN inhibitors demands the discovery of novel i... |
|
Structure-activity relationship of HIV-1 protease inhibitors containing alpha-hydroxy-beta-amino acids. Detailed study of P1 site.
Bioorg. Med. Chem. 7(9) , 2063-72, (1999) The structure-activity relationship of HIV-1 protease (HIV-1 PR) inhibitors containing alpha-hydroxy-beta-amino acids is discussed. We demonstrated that substituent groups on the P1 aromatic rings of ... |
3-Fluoro-6-methylbenzoic acid |
5-Fluoro-2-methylbenzoic acid |
QVR CF F1 |
5-Fluoro-2-methyl-benzoic acid |
5-Fluor-2-methyl-benzoesaeure |
Benzoic acid,5-fluoro-2-methyl |
MFCD00042294 |
Benzoic acid, 5-fluoro-2-methyl- |
2-methyl-5-fluorobenzoic acid |
5-Fluoro-o-toluic acid |
5-Fluoro-2-methyl benzoicacid |